ANAntonino Nicoletti

Antonino Nicoletti

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Antonino Nicoletti has a total of 471 co-authors. Here are the top co-authors by number of shared publications:

  • Giuseppina Caligiuri

    Université Paris Cité and Université Sorbonne Paris Nord, INSERM, LVTS, F-75018 Paris, France

    55 shared publications
  • Jean-Baptiste Michel

    Laboratory for Vascular Translational Science, Université de Paris, INSERM U1148, France (J. Cortese, C.R., G.E., C.C., J.M., A.N., J.-B.M., G.C.).

    22 shared publications
  • Olivier Thaunat

    CIRI, Centre International de Recherche en Infectiologie, Université de Lyon, INSERM U1111, Université Claude Bernard Lyon 1, CNRS, UMR5308, ENS de Lyon

    22 shared publications
  • Anh-Thu Gaston

    Inserm u1148 Biology of atherothrombosis, Paris, France

    17 shared publications
  • Jamila Khallou-Laschet

    Institut National de la Santé et de la Recherche Médicale (Inserm), U1148, "Laboratory of Vascular Translational Science", F-75018 Paris, France; Université Paris Diderot, Sorbonne Paris Cité, Faculté de Médecine, Site Xavier Bichat, F-75018 Paris, France; Département Hospitalo-Universitaire DHU "FIRE", F-75018 Paris, France

    17 shared publications
  • Marc Clement

    Université Paris Cité and Université Sorbonne Paris Nord, INSERM, Laboratory for Vascular Translational Science (LVTS)

    14 shared publications

Latest Publications

  • Open Access

    Fever-range temperature enhances B cells in vitro but is dispensable for the germinal center in vivo

    by Sofiane Mohammed, Zineb Sbihi, Patrick Laignel, Ines Houtia, Sabrina Haddou, Emanuele Procopio, Océane Morales, Grégory Franck, Giusepina Caligiuri, Antonino Nicoletti, et al.

    Fever is a conserved physiological response to immune activation characterized by elevated body temperature. While hyperthermia enhances innate and T cell immunity, its role in shaping the B cell compartment remains poorly defined, despite B cells’ role in long-term protection. Understanding how temperature modulates B cell physiology is relevant to vaccine strategies, particularly fever management around immunization. Therefore, we investigated the influence of fever-range thermal changes on humoral immunity. To decipher the direct effects, primary B cells from C57BL/6 mice were stimulated in vitro under mild hyperthermic conditions (∼1.5 °C increase). Fever-range temperature enhanced B cell activation, facilitated entry into cell division, and increased antigen presentation to CD4+ T cells, while transcriptomic analysis revealed enrichment of pathways involved in protein synthesis and mitochondrial respiration. To determine whether these intrinsic effects translated into altered humoral immunity in vivo , we developed a novel tunable implant-based system to induce localized, 48-hour hyperthermia around a draining lymph node in awake mice without altering core body temperature. Following subcutaneous NP-OVA/alum immunization, localized hyperthermia localized hyperthermia did not enhance antigen-specific germinal center B cell expansion, antibody titers or IgG affinity on day 9. Moreover, heating during priming did not affect the recall humoral response after a booster on day 21. Thus, fever-range temperature directly modulates murine B cell function in vitro but does not enhance humoral immunity in vivo , indicating that the biological consequences of intrinsic B cell thermosensitivity depend on its integration within the multicellular and inflammatory signals shaping germinal center responses.

  • Open Access

    Unveiling the Impact of Porphyromonas gingivalis ‐Associated Periodontitis on Stroke Outcome in Mice

    by Devy Diallo, Gabrielle Mangin, Banndith Cheat, Guillaume Even, Anh‐Thu Gaston, Jérome Bouchet, Jean‐Philippe Desilles, Marc Clement, Antonino Nicoletti, Giuseppina Caligiuri, et al.

    Background: Periodontitis is a chronic inflammatory condition with infectious origin that affects the tissues supporting the teeth. Increasing epidemiological evidence suggests that periodontitis is a risk factor for ischemic stroke with associated adverse outcomes. However, the underlying mechanism of this association remains incompletely elucidated. Methods: We used a C57BL/6J mice model of ischemic stroke induced by transitory occlusion of the middle cerebral artery in the presence or absence of ligature‐induced periodontitis using Porphyromonas gingivalis ‐soaked ligatures. Stroke severity was evaluated through infarct volume, sensorimotor deficit, blood–brain barrier (BBB) integrity, and markers of systemic and brain inflammation. The direct effect of P gingivalis on BBB endothelial cells was further explored in vitro. Results: Mice with P gingivalis ‐associated periodontitis showed a significant exacerbation of stroke severity: larger infarct volume, more severe sensorimotor deficit, greater BBB disruption, and increased brain neutrophil infiltration compared with sham. Systemic inflammation was also markedly elevated. Intravenous administration of P gingivalis alone, without gingival injury, before transitory occlusion of the middle cerebral artery was sufficient to amplify brain inflammation and stroke lesions. In vitro P gingivalis, through its gingipain proteases, directly impaired BBB integrity by increasing endothelial permeability and disrupting tight‐junction proteins. Conclusions: Our findings demonstrate that P gingivalis ‐associated periodontitis worsens ischemic stroke outcome both indirectly by enhancing systemic and brain inflammation and directly via BBB disruption. These results highlight periodontitis as a modifiable risk factor and potential therapeutic target for improving stroke prognosis.


  • Leukocyte-shed soluble CD31 unmasks coronary disease in low-risk outliers and provides source-specific inflammatory signatures of vulnerable plaques

    by Marco Magnoni, Daniele Andreini, Felicita Andreotti, Roberto Latini, Attilio Maseri, Antonino Nicoletti, Aldo Pietro Maggioni, Giuseppina Caligiuri


  • Open Access

    Inositol-Requiring Enzyme 1 pathway and autophagy drive sequential response of endothelial cells to febrile range hyperthermia

    by Julie Vorbe, Florence Massey, Corinne Rocher, Océane Morales, Nihal Brikci, Marie Le Borgne, Caligiuri Giuseppina, Antonino Nicoletti, Grégory Franck, Stéphane Illiano

    Context: Fever is an evolutionarily conserved and adaptive response during infections. However, prolonged fever has numerous systemic metabolic and functional side effects. In the heart, prolonged fever associated with infection is linked to fatal adverse effects, particularly involving impaired coronary circulation. Yet, the direct relationship between elevated temperature and coronary microcirculation dysfunction, remains to be fully demonstrated. In this study, we aimed to explore the specific responses of human coronary artery endothelial cells (HCAECs) to fever-range hyperthermia. Method: HCAECs were cultured at either 37°C or 40°C for up to 24 hours. Transcriptomic and proteomic profiles were obtained through microarray and mass spectrometry after 6, 12, and 24 hours of exposure. Key signaling pathways, upstream regulators, and candidate mechanisms were identified and validated at the mRNA and protein levels using mechanistic approaches. Results: Prolonged hyperthermia compromised HCAEC function, evidenced by cell detachment, loss of junctions, and increased permeability. HCAECs rapidly activated the unfolded protein response (UPR), including IRE1α activation and XBP1 splicing. Additionally, autophagic flux was significantly elevated, participating in the degradation of junction proteins. Pharmacological inhibition of IRE1α reduced the autophagic burden, protected against cell detachment, and preserved junction integrity over time. Conclusion: Our findings reveal that in response to fever-range hyperthermia, the IRE1α-autophagy axis regulates the survival and function of coronary endothelial cells. This mechanism could play a key role in modulating endothelial responses during infection and contribute to the pathological outcomes of fever. Furthermore, it may be relevant in local inflammatory conditions with elevated temperatures.

  • Open Access

    Camouflaging Endovascular Stents With an Endothelial Coat Using CD31 Domain 1 Mimetic Peptides

    by Jean Sénémaud, Charles Skarbek, Belen Hernandez, Ran Song, Zhongcheng Pan, Isabelle Lefevre, Elisabetta ฺBianchi, Yves Castier, Antonino Nicoletti, Christophe Bureau, et al.

    Background: Implantation of an endovascular device disrupts the homeostatic CD31:CD31 interactions among quiescent endothelial cells, platelets, and circulating leukocytes. The aim of this study was to mask endovascu-lar stents with peptides imitating CD31, to mimic the device's surface to resemble that of a healthy vascular endothelium. Methods: Peptide design relied on established trans-homophilic sequences found within domains 1 and 2 of CD31. Subsequently, synthetic peptides were immobilized onto flat CoCr and nitinol discs and their impact on the primary human arterial endothelial cell phenotype was evaluated in vitro. Following this, clinical-grade CoCr and nitinol endovascular devices were coated with one of the peptides that demonstrated the capability to induce a pro-physiologic endothelial phenotype, implanted in the arteries of rabbits, and compared to un-coated controls. Results: Membrane-distal CD31 domains 1 and 2 peptides exhibited a distinct capability to foster a healthy endothelial phenotype in vitro. By day 7 post-aortic implantation, CoCr stents were evenly covered by whole-some endothelial cells, devoid of thrombo-inflammatory signs, in contrast to both bare metal and drug-eluting stents. At day 60, nitinol-coated flow diverters demonstrated enhanced performance in comparison to the control groups for excluding experimental carotid aneurysms, facilitating the formation of a seamless "neo-arterial" wall. Conclusion: Membrane-distal CD31 biomimetic peptides effectively camouflage the device surface, prevent-ing local reactions and promoting rapid and seamless endovascular integration.

  • Open Access

    O-052 Sticky stents: a clot-adhesive coating on stent-retrievers reduces distal emboli

    by V Anagnostakou, C Skarbek, M Epshtein, E Propocio, C Raskett, R Romagnoli, G Iviglia, M Morra, M Antonucci, A Nicoletti, et al.

    Background The first-pass, complete recanalization by mechanical thrombectomy (MT) for the treatment of large vessel occlusion remains limited. Currently, stent-retrievers come with a variety of different designs with the goal of better clot integration, but there are no coatings available that can attract elements of the clot. Co-aspiration techniques can help retrieval of the main clot, but does not always prevent distal emboli, or emboli to a new territory (ENT). Clot specimens retrieved with MT have been shown to have dense meshes of extracellular DNA (neutrophil extracellular traps: NETs) on histology. We hypothesized that stent retrievers modified with coatings that bind to NETs will reduce distal emboli by anchoring the clot to the device. Methods Nickel-titanium plates were coated with 15 different substrates. Extensive characterization of candidate coatings was performed including X-Ray Photoelectron Spectroscopy, Atomic Force Microscopy and ζ - potential measurement. The plates were then exposed to both NETs and human peripheral whole blood in vitro. The amount of chromatin and platelet binding was measured with immunohistochemistry. The two best candidate coatings were then applied to the Solitaire device and tested in a validated simulated use experiment of MCA occlusion. Briefly, an aged clot that was confirmed to have NETs was introduced into a vascular replica of the entire circle of Willis. The two coated devices and two control devices (bare metal stent and stent with only the base polydopamine (PDA) film) were block randomized for mechanical thrombectomy in the model with 10 replicate experiments for each device. All effluent was collected from the MCA and ACA territories separately for emboli analysis to the distal vasculature and ENT, respectively. We also measured the number of passes required to achieve complete recanalization. Results Chromatin binding was increased with all compounds tested as compared to the bare metal alloy; however, the two best candidates were mustard benzo[b]furan (MBF) and a piperaquine derivative (Pipe-2) that showed a 3-fold and almost 2-fold affinity for chromatin, respectively. MBF and Pipe-2 also has reduced affinity for binding platelets compared to bare metal plates. These candidate compounds were tested in the simulated use experiment. The control devices had similar numbers of total fragmented emboli >200µm (bare metal: 55, PDA 49). Both candidate NETs binding coatings had a statistically significant reduction in total clot fragments released during MT as compared to the bare metal stent (MBF: 19; Pipe-2: 25; p=0.042). Although the final complete reperfusion was equivalent for all devices tested, in 70% of the thrombectomies the clot became dislodged from the bare metal stent in the ICA (which was then successfully aspirated). With the coating technologies, both MBF and Pipe-2, showed a dramatic reduction in the clot rolling off the stent, becoming dislodged in 20% or fewer of the MT procedures. Conclusion These experiments have shown that coating technologies targeting NETs of clots causing large vessel occlusion lead to fewer clot fragments during stent-retriever thrombectomy. It was also observed that the clot ‘rolling’ off the surface of the stent was reduced with chromatin binding surface modification. Disclosures V. Anagnostakou: None. C. Skarbek: None. M. Epshtein: None. E. Propocio: None. C. Raskett: None. R. Romagnoli: None. G. Iviglia: None. M. Morra: None. M. Antonucci: None. A. Nicoletti: 4; C; Kapto. G. Caligiuri: 4; C; Kapto. M. Gounis: 1; C; NIH, the United States – Israel Binational Science Foundation, Anaconda, ApicBio, Arsenal Medical, Axovant, Balt, Cerenovus, Ceretrieve, CereVasc LLC, Cook Medical, Galaxy Therapeutics, Gentuity, Gilb. 2; C; Alembic LLC, Astrocyte Pharmaceuticals, BendIt Technologies, Cerenovus, Imperative Care, Jacob’s Institute, Medtronic Neurovascular, Mivi Neurosciences, phenox GMbH, Q’Apel, Route 92 Medical, Scientia. 4; C; Imperative Care, InNeuroCo, Galaxy Therapeutics, Neurogami and Synchron.

  • Open Access

    Camouflaging Endovascular Stents with an Endothelial Coat Using CD31 Domain 1-mimetic Peptides

    by Jean Senemaud, Charles Skarbek, Tina Song, Zoncheng Pan, Isabelle Lefevre, Elisabetta Bianchi, Yves Castier, Antonino Nicoletti, Christophe Bureau, Giuseppina Caligiuri, et al.

    Background: Endovascular stents and flow diverters have become widely used for the treatment of vascular diseases; however, their effectiveness is often limited by the deposition and activation of blood platelets and leukocytes. The foreignness of these devices often triggers pathologic local reactions that impede their integration and compromise their efficacy. In this study, we developed a method to camouflage endovascular stents and flow diverters by coating them with a surface that mimics healthy endothelium, in order to promote more effective device integration and prevent the activation of blood cells. Methods: We designed peptides using domain 1 and/or domain 2 of human CD31 and synthesized the chosen peptide to coat clinical-grade nitinol flow diverters and cobalt chromium balloon expandable stents. The coated stents were implanted in adult rabbits and included control groups of uncoated devices and drug-eluting CoCr stents. The rabbits were monitored for 60 days, during which we assessed the integration of the devices under a physiologic confluence of endothelial cells. Results: Our results demonstrated that the stents coated with the CD31-Domain 1 mimicking peptide promoted a smooth integration of the devices under a physiologic confluence of endothelial cells. By day 7, the coated stents were entirely covered by a smooth endothelium, unlike bare-metal and drug-eluting stents which remained largely exposed to the flowing blood. By day 60, the coated stents demonstrated superiority over both bare-metal and drug-eluting stents, as they resulted in the formation of a “neo-arterial” wall at the entrance of the aneurysmal sac. Conclusion: Our method provides a promising step towards the development of more effective and biocompatible endovascular devices. The CD31 domain 1 coating prevented the pathologic local reaction at the site of stent implantation and promoted faster and more effective device integration. Further studies are necessary to investigate the efficacy and safety of CD31 domain 1 coatings on a larger scale, as well as their long-term durability and potential clinical applications.

  • Open Access

    Prolonged body temperature tuning in mice using radio frequency generating electromagnetic resonant circuit-system

    by Grégory Franck, Marie Le Borgne, Hélène Cazier, Patrick Laignel, Giuseppina Caligiuri, Antonino Nicoletti

    Rational In endothermic animals, body temperature (BT) is an evolutionary conserved and well characterized physical parameter that guarantees physiological functioning state. It results from the sum of bioenergetic processes of the body weighted by behavioral strategies, heat loss, and thermolytic processes. However, the intrinsic impact of temperature and temperature changes on the biology is far less understood. To date, the modification of the environmental temperature has constituted the main lever to evaluate the impact of thermic changes in small animal. However, studying intrinsic effect of temperature remains impossible using conventional laboratory equipment, mainly because hypothalamus instructed with information grabbed from the environmental temperature finely regulates and maintain body temperature around 37°C. Numerous pharmacological treatments have been used to block these thermoregulatory mechanisms, but confer high toxicity while dysregulating the central nervous responses and can potentially have confounding direct effects on studied peripheral tissues. Alternatively, physical methods using energy irradiation were reported, but they remain expensive and usually involve animal immobilization. We aimed at designing a simple and affordable device to adjust and maintain body temperature on the long course in conscious and free-moving animals. Method We developed an electromagnetic LC resonant circuit (ELM circuit) producing a radio frequency signal (64 kHz) inside a copper coil refrigerated with a water circuit. This setting is powered by a simple a 0-48V AC generator, allowing the use of a domestic electrical network. This setting can accommodate metal-free 3D-printed circular cages, where adult mice, previously implanted with thermometric ID transponders, are monitored remotely for intraperitoneal temperature over time. Results The BT of mice placed in the ELM circuit could be regulated in a reproducible fashion. Healthy mice increased their BT from 37 to 39.8±1°C, upon power supply ranging from 0 to 48V, respectively. In septic mice developing hypothermia (33±1 °C), BT could be either normalized to normothermia (37°C, 24V), or increased to fever-range hyperthermia (40°C, 48V) as a function of radiofrequency energy. BT tuning was accurate and stable for at least 12h. Blood count after 6 or 12 hours showed no modifications between groups, cardiomyocyte displayed heat shock response within the first hour in mice exposed to the maximal dose (BT=41°C). MALDI TOF imaging on brain microsections revealed modifications of the brain proteome, as suggested by differential PKC-theta, and prolactin 7B1 load in heated mice, as compared to controls. Conclusion Precise body temperature tuning is achievable in small animals, and could be of high interest to understand the impact of temperature in (patho)physiology.

  • Open Access

    Opposing Strain Directions on Adjacent Left Ventricular Segments Predict Fibrotic Remodeling after Acute Myocardial Infarction

    by Tania Dubois-Mignon, Varouna Syvannarath, Marylou Para, Sylvain Richard, Pierre Sicard, Antonino Nicoletti, Giuseppina Caligiuri, Grégory Franck

    Background: Despite similar levels of coronary occlusion and standard of care management, the occurrence of scarring over adaptive heart repair following acute myocardial infarction (AMI) remains unpredictable. Recent studies indicate that mechanical cues may modulate the transcriptional programs involved in tissue repair, possibly explaining why ventricular mechanical dyssynchrony an independent predictor of post-infarction outcome. Objective: Our study aimed to investigate the relationship between mechanical cues and the outcome of post-myocardial infarction heart remodeling by live imaging. Specifically, we examined the impact of individual variability of myocardial dyssynchrony, characterized by a divergent direction of injured left ventricle wall movement next to live tissue, on the formation of a large scar, dilation of the left ventricle, and loss of pumping function. Methods: We assessed the location and degree of regional systolic and diastolic dyssynchrony using transthoracic echocardiography coupled with speckle tracking imaging. Specifically, we measured the difference in absolute strain values between adjacent regions of the left ventricle at 5 days following the induction of a standard experimental infarction in female C57Bl6 mice. Three weeks later, transthoracic echocardiography was repeated to analyze the mass and global function of the left ventricle right before termination. We then examined the size of the scar in matched mid-sections of the left ventricle circumferential segments from each mouse using histomorphometry. Finally, we evaluated the potential impact on transcriptional tissue repair programs using spatial transcriptomic analysis on representative hearts with either adaptive or fibrotic post-infarction heart remodeling. Results: We analyzed all 96 systolic and diastolic strain-related parameters in the same 48 regions of the left ventricle in all mice, with echocardiographic and histological sections following the same orientation. Stepwise analysis of the live imaging data revealed that a combination of 8 regional strain parameters could predict fibrotic remodeling (Area under the ROC curve= 0.8290). We observed that scarring remodeling was associated with opposing trends of systolic and diastolic circumferential strain % delta values on adjacent regions at day 5, while adaptive remodeling at day 28 occurred when the trend followed the direction of control (sham) hearts. Cluster analysis of gene transcripts and speckle tracking assessment on representative hearts with adaptive or fibrotic post-infarction remodeling indicated a correlation between regional post-infarction dyssynchrony and the transcriptional program. Adrenergic receptors, including Adra1 , Trpc3 , and Myh7 , were found to be linked to specific regional dyssynchrony values and scarring remodeling. Conclusion: Our study demonstrates the potential of regional strain parameters obtained through live imaging in predicting fibrotic remodeling following myocardial infarction. Furthermore, our findings suggest a link between regional post-infarction dyssynchrony and the transcriptional program. These results highlight the potential applicability of our approach in clinical settings and provide insights for future personalization of therapeutic strategies.

  • Inverted direct allorecognition triggers early donor-specific antibody responses after transplantation

    by Xavier Charmetant, Chien-Chia Chen, Sarah Hamada, David Goncalves, Carole Saison, Maud Rabeyrin, Marion Rabant, Jean-Paul Duong van Huyen, Alice Koenig, Virginie Mathias, et al.

    The generation of antibodies against donor-specific major histocompatibility complex (MHC) antigens, a type of donor-specific antibodies (DSAs), after transplantation requires that recipient’s allospecific B cells receive help from T cells. The current dogma holds that this help is exclusively provided by the recipient’s CD4 + T cells that recognize complexes of recipient’s MHC II molecules and peptides derived from donor-specific MHC alloantigens, a process called indirect allorecognition. Here, we demonstrated that, after allogeneic heart transplantation, CD3ε knockout recipient mice lacking T cells generate a rapid, transient wave of switched alloantibodies, predominantly directed against MHC I molecules. This is due to the presence of donor CD4 + T cells within the graft that recognize intact recipient’s MHC II molecules expressed by B cell receptor–activated allospecific B cells. Indirect evidence suggests that this inverted direct pathway is also operant in patients after transplantation. Resident memory donor CD4 + T cells were observed in perfusion liquids of human renal and lung grafts and acquired B cell helper functions upon in vitro stimulation. Furthermore, T follicular helper cells, specialized in helping B cells, were abundant in mucosa-associated lymphoid tissue of lung and intestinal grafts. In the latter, more graft-derived passenger T cells correlated with the detection of donor T cells in recipient’s circulation; this, in turn, was associated with an early transient anti–MHC I DSA response and worse transplantation outcomes. We conclude that this inverted direct allorecognition is a possible explanation for the early transient anti-MHC DSA responses frequently observed after lung or intestinal transplantations.